cmp semaglutide/cyan 2.5mg/0.5mg/ml inj Semaglutide Flex-Dose 2 mL Injectable 2.5 mg/mL cmp semaglutide/cyan 2.5mg/0.5mg/ml inj Ozempic®

Ongoing research is being conducted to understand any potential long-term side effects of medications containing semaglutide, specifically their impact on the thyroid and gastrointestinal tract

Fast absorption, no injections

"2025 Employer Health Benefits Survey" and "Perspectives from Employers on GLP-1 Coverage." 19% of large employers (200+ workers) and 43% of very large employers (5,000+ workers) cover GLP-1s for weight loss in 2025

Clinical studies show that many patients lose between 10 and 15 percent of their body weight, with some losing up to 20 percent when combined with healthy eating and activity habits